# US Obesity Management Market

> 美国肥胖管理市场研究报告：按类型（外科手术、药物治疗、生活方式改变、健身计划）、按最终用户（诊所、医院、居家护理、健身中心）、按治疗方法（减重手术、药物、营养咨询、行为疗法）和按分销渠道（在线药房、零售药房、医院、直销） - 增长前景与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.73%
- **2024:** $ 871.5 Million
- **2025:** $ 930.15 Million
- **2035:** $ 1,784.1 Million
- **Key Players:** Novo Nordisk (DK), Bristol-Myers Squibb (US), Amgen (US), Eli Lilly and Company (US), Pfizer (US), Sanofi (FR), GSK (GB), Merck & Co. (US), AstraZeneca (GB)

**Report ID:** MRFR/Pharma/16774-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** September 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-obesity-management-market-18302

---

## Market Summary

## **US Obesity Management Market Overview**

As per MRFR analysis, the US Obesity Management Market Size was estimated at 816.9 (USD Million) in 2023. The US Obesity Management Market Industry is expected to grow from 871.5(USD Million) in 2024 to 1,785 (USD Million) by 2035. The US Obesity Management Market CAGR (growth rate) is expected to be around 6.735% during the forecast period (2025 - 2035).

### **Key US Obesity Management Market Trends Highlighted**

The US Obesity Management Market is shaped by several key market drivers that reflect the nation’s growing health concerns. With over 70% of American adults classified as overweight or obese, there is an increasing need for effective obesity management solutions. The rising recognition of obesity as a complex disease rather than a lifestyle choice has led to more comprehensive treatment approaches. Increasing focus on preventive measures, public health initiatives, and nutritional education programs further support this trend. Opportunities in this market can be found in the development of innovative weight-loss drugs and personalized nutrition plans tailored to individual needs.

Additionally, advances in digital health tools, including mobile applications and telehealth services, are expanding access to obesity management resources, making them more user-friendly and convenient for patients. In recent times, there has been a noticeable shift towards a multi-disciplinary approach in treating obesity, involving not only healthcare practitioners but also dietitians, psychologists, and fitness experts. This trend emphasizes holistic wellness strategies rather than relying solely on medications or surgical interventions. Moreover, the growth of community-based programs designed to tackle obesity through education and physical activity also highlights the concerted effort to address this public health challenge.

Other noteworthy trends include increased emphasis on mental health in the context of obesity, acknowledging its impact on weight management and the importance of psychological support in treatment plans. The rising demand for healthier food options and lifestyle change programs reflects the growing consumer awareness surrounding obesity and its health risks, creating a fertile ground for market expansion. Overall, these trends indicate a proactive stance towards managing obesity, making the US market increasingly dynamic and responsive to the needs of its population.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Obesity Management Market Drivers**

#### **Rising Obesity Rates in the US**

The escalating obesity rates in the United States significantly drive the US Obesity Management Market Industry. According to the Centers for Disease Control and Prevention (CDC), more than 42% of adults in the US were classified as obese in 2017-2018, marking a substantial increase from previous years. This uptick in obesity is linked to a higher prevalence of related health issues, including diabetes, heart disease, and certain cancers, which necessitate effective obesity management solutions.

Major organizations such as the American Heart Association have consistently raised awareness regarding these alarming statistics, further stressing the need for targeted obesity management programs, including lifestyle interventions, pharmacotherapy, and surgical options. As a result, as more individuals seek solutions to manage their weight, the demand for obesity management products and services is expected to rise substantially, indicating strong growth prospects for the market.

#### **Government Initiatives for Obesity Prevention**

Various governmental initiatives aimed at combating obesity significantly contribute to the growth of the US Obesity Management Market Industry. For example, the U.S. Department of Health and Human Services has launched programs such as 'Healthy People 2030', which sets benchmarks for health improvements, including a target to reduce obesity rates among adults and children. Initiatives like these not only create public awareness but also prompt increased funding and policy reforms focused on nutrition and physical activity.

The commitment to improve community health outcomes by organizations like the Food and Drug Administration helps to stimulate investment in obesity management solutions, leading to market expansion.

#### **Technological Advancements in Obesity Management**

Technological innovations in obesity management, including wearable fitness trackers and mobile health applications, are set to propel the US Obesity Management Market Industry forward. The Consumer Technology Association reported that 60% of U.S. adults were using some form of wearable technology to track their health in 2020. This interest in personal health management tools promotes adherence to weight management programs and enhances the overall effectiveness of these initiatives.

Respected companies in the tech space, such as Fitbit, have been at the forefront of these innovations, allowing users to track their physical activity, diet, and weight, ultimately leading to better health outcomes. The continuous integration of technology in health management highlights a promising avenue for growth in the obesity management sector.

### **US Obesity Management Market Segment Insights**

#### **Obesity Management Market Type Insights**

The US Obesity Management Market is witnessing significant growth with its diverse segmentation that includes Surgical Procedures, Pharmacotherapy, Lifestyle Changes, and Fitness Programs. Surgical Procedures, which comprise options such as bariatric surgery, play a crucial role in treating severe obesity and are often considered when other treatments have failed. This approach is critical as it often leads to substantial weight loss and improvement in associated health conditions such as diabetes and hypertension. On the other hand, Pharmacotherapy encompasses various medications designed to assist with weight loss by suppressing appetite or inhibiting fat absorption.

This segment is essential in providing patients who are not candidates for surgery with options to manage their obesity more effectively. 

Lifestyle Changes are also a vital category within the obesity management landscape, focusing on behavioral modifications through improved diet and physical activity. This segment emphasizes sustainable weight management practices, which are increasingly recognized for their long-term effectiveness in combating obesity. Lastly, Fitness Programs support individuals in their journey towards healthier lifestyles by promoting regular physical activity tailored to their specific needs. 

This diversification in the US Obesity Management Market segmentation permits healthcare providers to adopt a multi-faceted approach in addressing the obesity crisis, driven by various factors including rising obesity rates, an increasing awareness of health risks, and a growing emphasis on preventative healthcare measures. With the combined efforts in addressing obesity via these distinct methods, the market demonstrates a strong potential for addressing one of the pressing health issues faced by the US population.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

#### **Obesity Management Market End User Insights**

The US Obesity Management Market, with its focus on various End Users, demonstrates a dynamic landscape driven by growing health concerns related to obesity. Clinics and Hospitals play a crucial role, as they provide essential medical interventions and personalized care plans, which are vital for effective management of obesity. Home Care services have gained traction as they offer convenience and tailored solutions for obese patients, accommodating those who prefer treatments in a familiar environment. Fitness Centers contribute significantly by promoting active lifestyles and weight management through structured fitness programs and nutritional guidance. 

As obesity rates continue to rise in the US, driven by sedentary lifestyles and unhealthy eating habits, these End User segments are expected to adapt and innovate, enhancing their services to meet the demands of the population. The growing awareness of obesity-related health complications reinforces the importance of these segments, as they are critical in the prevention and treatment of obesity, making their roles central to the overall success of obesity management efforts within the market.

#### **Obesity Management Market Treatment Method Insights**

The Treatment Method segment of the US Obesity Management Market is a critical area focused on diverse approaches to tackle obesity, a condition affecting a substantial portion of the population. Among the various methods, Bariatric Surgery has gained considerable recognition for its effectiveness in achieving significant weight loss and improving comorbidities associated with obesity, making it an essential option for patients who have not succeeded with alternative treatments.

Pharmaceuticals represent another vital approach, offering an array of medications that assist in weight management and appetite control, thus catering to the needs of those who may not qualify for surgery or prefer non-invasive methods. 

Nutritional Counseling plays a significant role in educating individuals about healthy eating habits, which is crucial in preventing obesity through lifestyle changes. Additionally, Behavioral Therapy emphasizes changing unhealthy habits and establishing a supportive environment for weight management, addressing the psychological aspects of obesity. Collectively, these methods highlight the multifaceted nature of obesity treatment, demonstrating a robust response to an ongoing public health challenge in the United States, where obesity rates have risen significantly over the years.

As the US focuses on improving health outcomes, understanding the variations within the Treatment Method segment will be key to tailoring effective interventions for different patient needs.

#### **Obesity Management Market Distribution Channel Insights**

The Distribution Channel segment within the US Obesity Management Market encompasses diverse avenues such as Online Pharmacies, Retail Pharmacies, Hospitals, and Direct Sales. Online Pharmacies have gained traction due to their convenience and growing consumer preference for remote access to health solutions, enhancing patient compliance. Retail Pharmacies remain a key player, offering immediate access to obesity management medications and promoting patient engagement through personalized healthcare services. Hospitals play a critical role by integrating obesity management programs into broader patient care, addressing systemic health issues while providing specialized support. 

Direct Sales capitalize on personal interactions, enabling providers to deliver tailored solutions directly to consumers. The segment's evolution is driven by increasing obesity rates, shifting consumer behaviors, and advancements in telehealth solutions. Emerging technology in the healthcare sector, particularly digital platforms, is expected to redefine how patients access and manage obesity treatments, shaping the landscape of the US Obesity Management Market. Moreover, rising health awareness and preventive care trends significantly influence consumer choices in selecting suitable distribution channels, thereby fueling the market growth.

### **US Obesity Management Market Key Players and Competitive Insights**

The US Obesity Management Market has been experiencing significant growth driven by the increasing prevalence of obesity and related health issues among the population. The competitive landscape is characterized by the presence of numerous pharmaceutical companies and healthcare providers that are actively investing in the development of innovative treatments and solutions for obesity management. With various therapeutic approaches, including pharmacotherapy, behavioral interventions, and surgical options, the market has become an attractive arena for stakeholders. Companies are focusing on advancing their product pipelines and leveraging strategic collaborations to enhance their market presence.

As awareness around obesity continues to rise, driven by public health initiatives and evolving consumer perspectives, organizations are increasingly aligning their strategies to cater to the diverse needs of patients across the United States.

Bristol Myers Squibb has established itself as a formidable player in the US Obesity Management Market. The company benefits from its robust research and development capabilities, which enable it to explore novel obesity treatment options tailored for various patient demographics. Its strong reputation and longstanding presence in the pharmaceutical industry have allowed Bristol Myers Squibb to foster collaborative relationships with healthcare providers and institutions. This collaborative approach facilitates the integration of clinical insights into the development process, ensuring that the therapies meet real-world needs.

The company’s focus on patient-centered care and dedication to improving outcomes for individuals with obesity positions it favorably in the competitive landscape, solidifying its commitment to addressing this pressing health issue.

Eli Lilly is another key entity in the US Obesity Management Market, recognized for its innovative pharmaceuticals aimed at weight management. The company has made significant strides with its key products that target obesity, focusing on science-backed solutions that cater to a diverse patient base. Eli Lilly's established market presence, bolstered by a comprehensive marketing strategy, has allowed it to effectively reach and engage healthcare professionals and patients alike. The company’s strengths lie in its commitment to research and development, leading to a consistent pipeline of new treatments.

Moreover, Eli Lilly has been proactive in expanding its portfolio through strategic mergers and acquisitions, enhancing its ability to offer cutting-edge therapies that address obesity and its comorbidities. This approach not only strengthens the company’s foothold in the obesity treatment market segment but also underscores its dedication to mitigating the obesity epidemic in the United States.

### **Key Companies in the US Obesity Management Market Include**

### **US Obesity Management Market Industry Developments**

Recent developments in the US Obesity Management Market indicate significant growth driven by increased awareness of obesity's health impacts. Companies like Bristol Myers Squibb and Eli Lilly are actively expanding their portfolios with innovative solutions, such as weight management drugs and comprehensive care plans. Recently, in September 2023, Eli Lilly announced the acquisition of a promising obesity drug platform, enhancing its competitive position in the market. Novo Nordisk continues to advance its obesity treatments, recently reporting a substantial revenue increase from their GLP-1 receptor agonists, emphasizing the demand for effective management solutions.

Additionally, Medtronic is focusing on technological solutions for obesity management, showcasing advancements in obesity-related medical devices. Meanwhile, Zafgen's recent clinical trials highlight promising results for its weight-loss drug candidates. Over the past two years, the market valuation for companies like Amgen and AbbVie has significantly risen, attributed to novel therapies and public health initiatives addressing the obesity epidemic in the US. Legislative measures aimed at increasing access to obesity treatments are also evolving, thereby potentially influencing market dynamics ahead.

### **US Obesity Management Market Segmentation Insights**

#### **Obesity Management Market Type Outlook**

#### **Obesity Management Market End User Outlook**

#### **Obesity Management Market Treatment Method Outlook**

#### **Obesity Management Market Distribution Channel Outlook**

## Market Drivers

### Rising Healthcare Costs

与肥胖相关的健康问题的不断上升的成本是肥胖管理市场的一个关键驱动因素。在美国，肥胖相关的医疗费用估计每年超过1470亿美元，给医疗系统带来了巨大的负担。这种财务压力促使医疗服务提供者和保险公司将肥胖管理作为降低长期成本的一种手段。因此，肥胖管理市场越来越强调预防措施和有效的治疗选择。随着利益相关者认识到肥胖的经济影响，投资于创新管理解决方案的可能性将增加，从而促进一个更具活力的市场环境。

### Increasing Obesity Rates

肥胖管理市场受到美国肥胖率上升的显著影响。最近的数据表明，2017-2018年约有42.4%的成年人被归类为肥胖，这一数字在随后的几年中可能有所增加。这一令人担忧的趋势需要有效的管理策略，推动对各种肥胖管理解决方案的需求。肥胖相关健康状况的日益普遍，例如糖尿病和心血管疾病，进一步强调了全面肥胖管理项目的必要性。随着医疗服务提供者和政策制定者认识到应对这一公共健康危机的紧迫性，预计对肥胖管理市场倡议的投资将增长，可能导致未来几年市场格局更加稳健。

### Advancements in Medical Treatments

肥胖的医疗治疗创新正在重塑肥胖管理市场。新药物和外科干预的开发扩大了肥胖患者可用的选择。例如，最近的减重手术技术的进步改善了患者的结果并缩短了恢复时间。此外，新型减肥药物的引入为医疗专业人员提供了更多有效应对肥胖的工具。随着这些医疗治疗获得认可并证明其有效性，它们可能会吸引更多寻求解决方案的患者，从而推动肥胖管理市场的增长。对个性化医疗的日益关注也可能增强治疗效果，进一步刺激市场扩展。

### Government Initiatives and Policies

旨在应对肥胖的政府倡议在塑造肥胖管理市场中发挥着关键作用。各种联邦和州项目正在实施，以促进更健康的生活方式并改善对肥胖管理资源的获取。例如，鼓励身体活动和更好营养的倡议正在获得关注，可能导致对肥胖管理服务的需求增加。此外，支持肥胖治疗研究和开发的政策可能会改善市场格局。随着这些政府努力的不断发展，预计将为肥胖管理市场创造一个更有利的环境，鼓励创新和可及性。

### Growing Awareness of Health and Wellness

美国人口对健康和保健意识的提高正在显著影响肥胖管理市场。随着个人对肥胖相关风险的了解加深，对有效管理解决方案的需求也在增加。这一趋势反映在减肥项目、健身计划和营养咨询服务的日益普及上。此外，社交媒体和数字平台的兴起促进了关于肥胖管理信息的传播，进一步推动了消费者的兴趣。随着意识的不断扩大，肥胖管理市场可能会经历持续增长，越来越多的人寻求资源以实现和维持健康体重。

## Future Outlook

预计肥胖管理市场将在2025至2035年间以6.73%的年均增长率增长，推动因素包括肥胖率上升、技术进步和健康意识增强。

到2035年，肥胖管理市场预计将强劲增长，受创新解决方案和消费者需求增加的推动。

## Segment Insights

### 按类型：外科手术（最大）与药物治疗（增长最快）

在美国的[肥胖管理市场](https://www.marketresearchfuture.com/reports/obesity-management-market-2690)中，不同细分市场的份额分布反映了应对肥胖的多样化方法。外科手术占据最大份额，因其在严重病例中的有效性和医疗必要性。药物治疗作为传统外科方法的替代或补充，正在显著被采用，表明治疗偏好向更少侵入性选项的转变。市场增长趋势显示，外科手术因其确立的疗效继续主导。然而，药物治疗作为增长最快的细分市场正在崛起，受到药物配方进步及其在门诊护理中接受度的推动。这一转变突显了一个更广泛的战略，专注于满足不同患者需求的个性化治疗计划。

外科手术：主导与药物治疗：新兴

外科手术在美国肥胖管理市场中发挥着主导作用，其特点是胃旁路和袖状胃切除等方法，为患者带来显著的减重和健康改善。这些手术通常保留给患有严重肥胖及相关健康并发症的个体。另一方面，药物治疗正在成为一个新兴细分市场，随着创新药物的推出，帮助进行体重管理。这些药物提供了一种非侵入性的替代方案，并越来越受到医疗专业人士的推荐，反映出对肥胖治疗的更全面的方法。这两个细分市场突显了量身定制的医疗策略在满足患者需求方面的重要性。

### 按最终用户：诊所（最大）与居家护理（增长最快）

在美国肥胖管理市场中，最终用户的分布在诊所、医院、居家护理提供者和健身中心之间显著多样化。诊所由于其集中于个体患者管理和量身定制干预计划的努力，拥有最大的市场份额。医院也发挥着关键作用，但其份额略低，因为它们主要关注急性护理而非持续管理。另一方面，居家护理正在获得关注，因为它符合患者对便利和个性化服务的偏好，吸引那些需要在家中获得持续支持的人。对于这些细分市场的增长趋势显示，居家护理解决方案正在显著转变，现在被认为是增长最快的细分市场。增长受到技术进步的推动，这些进步促进了远程监测和虚拟咨询，提高了患者的可及性。此外，对肥胖健康影响的日益关注导致对全面管理策略的需求增加，包括在熟悉的环境中如家中继续护理，进一步推动了这一细分市场的快速扩展。

诊所（主导）与居家护理（新兴）

诊所因其专业功能和提供个性化护理的能力而在美国肥胖管理市场中脱颖而出。它们提供专门的计划，旨在长期体重管理，包括营养咨询和心理支持。通过以患者为中心的方法，诊所吸引了寻求量身定制肥胖解决方案的个体的稳定流量。相反，居家护理代表了一个新兴细分市场，利用技术提供灵活和个性化的支持。其增长受到向以患者为中心的护理转变的推动，使个体能够在舒适的家中获得帮助。这个细分市场特别吸引那些偏好便利并需要持续管理的患者，整合健康监测设备和远程医疗解决方案，以增强患者体验。

### 按治疗方法：减重手术（最大）与药物（增长最快）

在美国肥胖管理市场中，各细分市场的价值在市场份额上表现出明显的分布，减重手术因其在减重和相关健康改善方面的有效性而占据最大份额。虽然药物干预的市场份额较小，但其显著的接受度反映了向可注射肥胖治疗的转变，为患者提供了更多的选择，除了传统方法。随着健康意识的提高和新药的监管批准扩大，药物的需求预计将上升，使其成为增长最快的细分市场。这一激增受到药物配方进步和对药物作为可行的体重管理选项的日益接受的推动。这些趋势表明在治疗肥胖方面采取了多样化的方法，以满足各种患者的需求和偏好。

减重手术：主导与药物：新兴

减重手术在美国肥胖管理市场中仍然是主导的治疗方法，其特点是通过外科干预进行全面的减重方法。它通常推荐给患有严重肥胖的患者，并提供可观的长期减重结果。另一方面，药物正在迅速崛起，成为一种竞争选项，特别是在药物治疗的最新创新方面。这些药物，包括食欲抑制剂和代谢增强剂，为那些可能不适合手术的患者提供了替代途径。制药领域的持续研究和开发可能会提高这些治疗的有效性和可及性，使其成为解决肥胖的补充选项。

### 按分销渠道：零售药房（最大）与在线药房（增长最快）

在美国肥胖管理市场中，零售药房因其广泛的覆盖面和建立的客户基础而占据最大的市场份额。它们是药物和肥胖管理产品的可信来源，为消费者提供便利和可及性。在线药房虽然目前的市场份额较小，但作为传统零售渠道的替代选项迅速获得关注，尤其是在寻求灵活性和隐私的科技精明消费者中。该细分市场的增长趋势受到肥胖相关健康问题意识提高、在线药房平台提供的便利以及向更个性化医疗解决方案转变等因素的影响。医院也保持着显著的存在，因为它们提供全面的治疗计划，而直接销售渠道则作为一个专注于为消费者提供个性化产品的细分市场正在崛起。这些趋势的融合表明肥胖管理领域的动态演变。

零售药房（主导）与在线药房（新兴）

零售药房在美国肥胖管理市场中发挥着主导作用，利用其建立的网络、可及性和患者的信任。它们是消费者寻求不仅仅是药物，还有针对肥胖管理的咨询和营养产品的主要目的地。相反，在线药房正在崛起，成为一个强大的参与者，吸引优先考虑便利和隐私的年轻人群体。这些平台通常提供具有竞争力的定价和更广泛的产品选择，通过创新的数字营销策略和消费者对电子商务的偏好促进增长。随着这两个细分市场的不断发展，它们相辅相成，满足多样化的消费者需求和偏好，从而增强整体市场动态。

## Competitive Benchmarking

肥胖管理市场目前的特点是动态竞争环境，受到肥胖相关健康问题的日益关注和发病率上升的驱动。诺和诺德（丹麦）、礼来公司（美国）和安进（美国）等主要参与者在战略上定位以利用创新和合作伙伴关系来增强其市场存在。诺和诺德（丹麦）专注于开发先进的药物解决方案，而礼来公司（美国）则强调药物开发和数字健康倡议的结合。安进（美国）似乎正在投资生物技术进步，以创造更有效的治疗方案，共同塑造一个优先考虑创新和以患者为中心的解决方案的竞争环境。市场结构适度分散，多个参与者通过各种商业策略争夺市场份额。公司越来越多地本地化制造以降低成本和优化供应链，这在一个及时获取治疗可能显著影响患者结果的市场中至关重要。这些主要参与者的集体影响促进了一个竞争氛围，鼓励持续改进和适应市场需求。
在十月，礼来公司（美国）宣布与一家领先的数字健康公司建立战略合作伙伴关系，通过集成技术增强其肥胖管理解决方案。这一合作旨在为患者提供个性化治疗计划和实时健康监测，表明肥胖管理中向更整体方法的转变。这些举措不仅增强了患者参与度，还使礼来在技术与医疗保健整合方面成为领导者。
在九月，诺和诺德（丹麦）启动了其最新肥胖药物的新临床试验，旨在更有效地针对代谢途径。这一举措强调了该公司对创新的承诺，以及其专注于开发针对肥胖根本原因而不仅仅是症状的治疗方案。该试验的预期结果可能会显著影响肥胖管理领域的治疗方案和患者结果。
在八月，安进（美国）通过收购一家专注于肥胖相关基因研究的生物科技初创公司来扩大其研究能力。这一收购可能会增强安进的产品组合，并提供有关影响肥胖的遗传因素的见解，可能导致突破性的疗法。这些战略行动反映了公司通过先进的研究方法加深对肥胖理解的更广泛趋势。
截至十一月，肥胖管理市场的竞争趋势越来越多地由数字化、可持续性和人工智能（AI）在治疗方案中的整合所定义。战略联盟变得越来越普遍，因为公司认识到合作努力在应对复杂健康挑战中的价值。展望未来，竞争差异化预计将演变，明显从基于价格的竞争转向创新、技术整合和供应链可靠性。这一转变最终可能导致更有效和个性化的肥胖管理解决方案，提升患者护理和结果。

## Recent News & Developments

美国肥胖管理市场的最新发展表明，由于对肥胖健康影响的认识增加，市场正在显著增长。百时美施贵宝和礼来等公司正在积极扩展其产品组合，推出创新解决方案，如体重管理药物和综合护理计划。最近，在2023年9月，礼来宣布收购一个有前景的肥胖药物平台，增强其在市场中的竞争地位。诺和诺德继续推进其肥胖治疗，最近报告其GLP-1受体激动剂的收入大幅增加，强调了对有效管理解决方案的需求。

此外，美敦力专注于肥胖管理的技术解决方案，展示了与肥胖相关的医疗设备的进步。同时，Zafgen最近的临床试验突显了其减重药物候选者的良好结果。在过去两年中，安进和艾伯维等公司的市场估值显著上升，这归因于新疗法和公共卫生倡议应对美国的肥胖流行。旨在增加肥胖治疗获取的立法措施也在不断演变，从而可能影响未来的市场动态。

## Report Scope

| 市场规模 2024 | 871.5（百万美元） |
| --- | --- |
| 市场规模 2025 | 930.15（百万美元） |
| 市场规模 2035 | 1784.1（百万美元） |
| 年均复合增长率（CAGR） | 6.73%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 百万美元 |
| 主要公司简介 | 诺和诺德（丹麦），百时美施贵宝（美国），安进（美国），礼来公司（美国），辉瑞（美国），赛诺菲（法国），葛兰素史克（英国），默克公司（美国），阿斯利康（英国） |
| 覆盖的细分市场 | 类型、最终用户、治疗方法、分销渠道 |
| 主要市场机会 | 数字健康解决方案的整合增强了个性化肥胖管理策略和患者参与。 |
| 主要市场动态 | 消费者对个性化肥胖管理解决方案的需求上升推动了市场的创新和竞争。 |
| 覆盖的国家 | 美国 |

## Frequently Asked Questions

**Q: 2024年美国肥胖管理市场的市场估值是多少？**
A: 市场估值在2024年为8.715亿美元。

**Q: 2035年美国肥胖管理市场的预计市场估值是多少？**
A: 2035年的预计市场估值为17.841亿美元。

**Q: 在2025年至2035年的预测期内，美国肥胖管理市场的预期年复合增长率（CAGR）是多少？**
A: 在2025年至2035年的预测期内，预期年复合增长率为6.73%。

**Q: 哪些公司被认为是美国肥胖管理市场的关键参与者？**
A: 关键参与者包括诺和诺德、百时美施贵宝、安进、礼来公司、辉瑞、赛诺菲、葛兰素史克、默克公司和阿斯利康。

**Q: 美国肥胖管理市场的主要细分领域是什么？**
A: 主要细分领域包括类型、最终用户、治疗方法和分销渠道。

**Q: 美国肥胖管理市场中外科手术的估值范围是多少？**
A: 外科手术的估值范围为2.00亿美元到4.00亿美元。

**Q: 2024年药物治疗细分市场对市场的贡献是多少？**
A: 药物治疗细分市场的贡献在2.50亿美元到5.00亿美元之间。

**Q: 美国肥胖管理市场中健身项目的预计估值是多少？**
A: 健身项目的预计估值范围为1.215亿美元到2.841亿美元。

**Q: 作为最终用户，医院的估值范围是多少？**
A: 作为最终用户，医院的估值范围在3.00亿美元到6.00亿美元之间。

**Q: 美国肥胖管理市场中药品细分市场的预期增长趋势是什么？**
A: 药品细分市场预计将增长，估值范围为3.00亿美元到6.00亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-obesity-management-market-18302*